Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review-Reference-Cited by-同舟云学术

Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review

Published:2022-04 Issue: Volume:172 Page:103649
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Servetto Alberto,Salomone Fabio,Di Costanzo Fabrizio,Iuliano Rossella,Marandino Laura,Napolitano Fabiana,Santaniello Antonio,De Placido Pietro,De Placido Sabino,Di Maio Massimo,Formisano Luigi,Bianco Roberto

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference26 articles.

1. Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis;Barroso-Sousa;JAMA Oncol.,2018

2. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards;Bottomley;Lancet Oncol.,2016

4. Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy;Bylicki;Ann. Oncol. Off. J. Eur. Soc. Med. Oncol.,2015

5. The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment;Carrera;CA. Cancer J. Clin.,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS);HemaSphere;2024-05

2. High LGALS3 expression induced by HCP5/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma;Cancer Cell International;2024-04-20

4. Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors;Cancers;2023-12-04

5. Assessment of Patient-Reported Outcomes in Industry-Sponsored Phase I Oncology Studies: Considerations for Translating Theory Into Practice;Value in Health;2023-10